These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 20123551

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor.
    Newman-Tancredi A, Cussac D, Audinot V, Nicolas JP, De Ceuninck F, Boutin JA, Millan MJ.
    J Pharmacol Exp Ther; 2002 Nov; 303(2):805-14. PubMed ID: 12388667
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications.
    Clark D, White FJ.
    Synapse; 1987 Nov; 1(4):347-88. PubMed ID: 2971273
    [Abstract] [Full Text] [Related]

  • 28. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE, Tseng T, Brusniak MY, Ginsburg B, Pearlman RS, Teeter M, DuRand C, Starr S, Neve KA.
    J Med Chem; 1998 Oct 22; 41(22):4385-99. PubMed ID: 9784114
    [Abstract] [Full Text] [Related]

  • 29. Synergistic interactions of D1- and D2-selective dopamine agonists in animal models for Parkinson's disease: sites of action and implications for the pathogenesis of dyskinesias.
    Robertson HA.
    Can J Neurol Sci; 1992 Feb 22; 19(1 Suppl):147-52. PubMed ID: 1349263
    [Abstract] [Full Text] [Related]

  • 30. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
    Chio CL, Lajiness ME, Huff RM.
    Mol Pharmacol; 1994 Jan 22; 45(1):51-60. PubMed ID: 8302280
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The novel antidyskinetic drug sarizotan elicits different functional responses at human D2-like dopamine receptors.
    Kuzhikandathil EV, Bartoszyk GD.
    Neuropharmacology; 2006 Sep 22; 51(4):873-84. PubMed ID: 16844149
    [Abstract] [Full Text] [Related]

  • 34. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
    Depoortère R, Bardin L, Rodrigues M, Abrial E, Aliaga M, Newman-Tancredi A.
    Behav Pharmacol; 2009 Jul 22; 20(4):303-11. PubMed ID: 19584712
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
    Millan MJ, Mannoury la Cour C, Novi F, Maggio R, Audinot V, Newman-Tancredi A, Cussac D, Pasteau V, Boutin JA, Dubuffet T, Lavielle G.
    J Pharmacol Exp Ther; 2008 Feb 22; 324(2):587-99. PubMed ID: 18024789
    [Abstract] [Full Text] [Related]

  • 37. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
    Sautel F, Griffon N, Sokoloff P, Schwartz JC, Launay C, Simon P, Costentin J, Schoenfelder A, Garrido F, Mann A.
    J Pharmacol Exp Ther; 1995 Dec 22; 275(3):1239-46. PubMed ID: 8531087
    [Abstract] [Full Text] [Related]

  • 38. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
    Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HH, Niznik HB.
    Nature; 1991 Apr 18; 350(6319):614-9. PubMed ID: 1826762
    [Abstract] [Full Text] [Related]

  • 39. [Brain dopamine receptors. Interactions between D1 and D2 receptors, and dopamine mediated behaviour].
    Costentin J.
    Therapie; 1991 Apr 18; 46(4):269-82. PubMed ID: 1683022
    [Abstract] [Full Text] [Related]

  • 40. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells.
    McAllister G, Knowles MR, Ward-Booth SM, Sinclair HA, Patel S, Marwood R, Emms F, Patel S, Smith A, Seabrook GR.
    J Recept Signal Transduct Res; 1995 Apr 18; 15(1-4):267-81. PubMed ID: 8903944
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.